Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Avatar Builder | Contact Info | Update Email | Update Password | Leaderboards | Manage Favourite | Reputation | Reputation History | Subscriptions | Payment Info | Invoices | Favourites

Bullboard Post History

by funky99

Order by:

V.HTL	RE:Q3 call link here you go: https://www.hamiltonthorne.ltd/index.php/investors/financial... December 5, 2018
ATBPF	RE:RE:RE: context of the market!!! Incoherent move from management and I am not the one who think the same in my... May 26, 2017
ATBPF	RE:RE:RE:What am I missing? Been a long time investor here and I am disapointed about management not able... May 25, 2017
ATBPF	RE:Antibe Therapeutics grants options to purchase common shares Giving free candies again....I would rather prefer see management buying a... April 3, 2017
ATBPF	Bloom Burton & Co Healthcare Investor Conference May 2017 Antibe Therapeutics will be presenting at the Bloom Burton & Co... March 9, 2017
T.GUD	Samira Sakhia re-elected board of Antibe Therapeutics ATE.V Samira Sakhia of Knight Therapeutics has been re-elected to the board of... March 8, 2017
ATBPF	Antibe Therapeutics Inc. Announces Results of AGM Good to see Samira Sakhia of Knight Therapeutics re-elected to the board... March 8, 2017
ATBPF	RE:RE:RE:RE:ATE Trading Interesting that Knight Therapeutics got 240000 shares. Still no insider... March 2, 2017
ATBPF	Antibe Therapeutics Reports Q3 2017 Interim Financial and Op http://finance.yahoo.com/news/antibe-therapeutics-reports-q3-2017-234500342... March 1, 2017
ATBPF	RE:Why the sell off? Don't understand neither, looked like it was day traders that came and... March 1, 2017
ATBPF	RE:RE:RE:RE:RE:RE:RE:RE:NR says 1% of Market which means Poor Opinion see you have done extensive Due Dilligence as well to know about... February 24, 2017
ATBPF	RE:RE:RE:RE:RE:RE:NR says 1% of Market which means Phase II placebo-controlled dose-ranging trial is fully funded from part of... February 24, 2017
ATBPF	RE:RE:RE:RE:RE:nice ! Great news of a non-dillutive funding to continue clinical trials. Slowly but... February 24, 2017
ATBPF	Queen's Healthcare & Business Conference Scott Curtis - VP, Business Development at Antibe Therapeutics will be... January 27, 2017
ATBPF	Banff Inflammation Workshop 2017 https://www.ucalgary.ca/biw2017/contact January 27, 2017
ATBPF	RE:RE:Where is this headedÉ Just to clarify Antibe is conducting 2 additional phase II studies per... January 11, 2017

Featured News Links

Do you want to stay ahead of the markets? See how DealRoom can help.

Featured Company

Spod Lithium Corp. C.SPOD

Spod Lithium Corp. is a Canada-based exploration and development company focused on unlocking the potential of lithium ... view more »